Market Exclusive

Analyst Downgrades – Portola Pharmaceuticals (NASDAQ:PTLA) Stock Gets Downgraded By Morgan Stanley from Overweight to Equal Weight

Analyst Ratings For Portola Pharmaceuticals (NASDAQ:PTLA)

Today, Portola Pharmaceuticals (NASDAQ:PTLA) stock was downgraded by Morgan Stanley from Overweight to Equal Weight with a price target of $65.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Portola Pharmaceuticals (NASDAQ:PTLA)
Portola Pharmaceuticals (NASDAQ:PTLA) has insider ownership of 5.50% and institutional ownership of 86.45%.

Recent Trading Activity for Portola Pharmaceuticals (NASDAQ:PTLA)
Shares of Portola Pharmaceuticals closed the previous trading session at 30.85 down -11.47 27.10% with 30.100000381469727 shares trading hands.

Exit mobile version